Exosome Characterization with FFF-MALS-DLS

Significance of the Topic

Exosomes are nanoscale extracellular vesicles released by cells that carry proteins, nucleic acids and lipids reflecting their cell of origin. They have emerged as promising noninvasive biomarkers for disease diagnosis, prognosis and therapy monitoring. Reliable isolation and detailed biophysical characterization of exosomes are essential to ensure reproducibility and meaningful interpretation of downstream molecular analyses.

Objectives and Study Overview

This white paper presents a comprehensive workflow for exosome separation and characterization using field-flow fractionation (FFF) coupled with multi-angle light scattering (MALS) and dynamic light scattering (DLS). The goals are to describe the underlying principles of FFF, demonstrate online method development and automation tools, illustrate strategies to enhance fraction purity and concentration, and highlight applications in basic research and clinical biomarker discovery.

Methodology and Instrumentation

Field-flow fractionation separates particles by balancing cross-flow-driven transport toward an ultrafiltration membrane against Brownian diffusion away from it. Smaller particles diffuse farther from the membrane and elute earlier under a parabolic carrier flow profile. Key software tools include VISION DESIGN for in silico method development and VISION RUN for automated control of pumps, autosampler and detectors. Major instrumentation components are:

• Eclipse FFF separation unit with thin channel and ultrafiltration membrane.
• DAWN MALS instrument equipped with an embedded WyattQELS DLS module for simultaneous measurement of radius of gyration and hydrodynamic radius.
• Optilab differential refractive index detector and UV/Vis absorbance detector for concentration and composition analysis.
• Dilution Control Module (DCM) that actively diverts excess carrier fluid to reduce sample dilution by up to 20× without compromising detector flow stability.
• Mobility EAF4 channel with integrated electrodes to measure zeta potential and charge by observing shifts in retention time under applied electric fields.

Key Findings and Discussion

Combining FFF with MALS and DLS provides high‐resolution separation and simultaneous size characterization across a broad range (1–500 nm). In serum analysis, DLS readily identifies abundant proteins and lipoproteins, while MALS accurately measures the size of exosomes and larger particles. Online concentration measurement by MALS and UV/Vis enables quantification of each fraction. Electrophoretic FFF (EAF4) further resolves vesicles by charge, yielding zeta potential distributions without additional sample preparation.

Applied to cell culture and biological fluids, this platform has revealed three distinct subpopulations of small extracellular vesicles: small exosome vesicles, large exosome vesicles and nonmembranous exomeres. These classes differ in size, surface markers, glycosylation patterns and cargo profiles, underscoring the importance of precise biophysical fractionation before molecular analysis.

Benefits and Practical Applications

FFF-MALS-DLS supports label-free, low-shear isolation of exosomes directly from complex matrices such as serum or urine. Key advantages include:

• High resolution size separation enabling discrimination of vesicles from protein aggregates and lipoproteins.
• Unbiased size and structural information through complementary MALS and DLS detection.
• Controlled dilution to preserve low-abundance vesicle populations.
• Capability to collect size‐defined fractions for downstream imaging, proteomics, genomics or functional assays.
• Zeta potential measurement for assessing vesicle surface charge and stability.

Future Trends and Applications

Advances are expected in integrating FFF-MALS-DLS with mass spectrometry, fluorescence detection and microfluidic sample handling to enable multiparametric vesicle profiling. High-throughput, automated workflows and standardized protocols will facilitate comparative studies across laboratories. Emerging applications include personalized diagnostics, monitoring of immune responses and quality control in biomanufacturing of nanotherapeutics.

Conclusion

Field-flow fractionation coupled with online MALS and DLS represents a versatile platform for robust exosome isolation, detailed biophysical characterization and quantitative fraction collection. The addition of dilution control and electrophoretic separation modules further enhances its capability to resolve vesicle subpopulations by size and charge. Adoption of this integrated approach can accelerate biomarker discovery, improve reproducibility and drive new insights into extracellular vesicle biology.

References

• Zhang H et al Identification of distinct nanoparticles and subsets of extracellular vesicles by asymmetric-flow field-flow fractionation Nat Cell Biol 2018
• Sitar S et al Size characterization and quantification of exosomes by asymmetrical-flow field-flow fractionation Anal Chem 2015
• Petersen KE et al A review of exosome separation techniques and characterization of B16-F10 mouse melanoma exosomes with AF4-UV-MALS-DLS-TEM Anal Bioanal Chem 2014
• Yang JS et al Size dependent lipidomic analysis of urinary exosomes from patients with prostate cancer by flow field-flow fractionation and nanoflow LC-MS Anal Chem 2017
• A protocol for asymmetric-flow field-flow fractionation (AF4) of small extracellular vesicles Nat Protoc 2018
• Agarwal K et al Analysis of exosome release as a cellular response to MAPK pathway inhibition Langmuir 2015
• Ashames AA Development of separation methods to produce uniform exosome subpopulations using field-flow fractionation Colorado School of Mines 2015
• Kang D et al Proteomic analysis of exosomes from human neural stem cells by flow field-flow fractionation and nanoflow LC-MS J Proteome Res 2008